JP2021191784A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021191784A5 JP2021191784A5 JP2021143227A JP2021143227A JP2021191784A5 JP 2021191784 A5 JP2021191784 A5 JP 2021191784A5 JP 2021143227 A JP2021143227 A JP 2021143227A JP 2021143227 A JP2021143227 A JP 2021143227A JP 2021191784 A5 JP2021191784 A5 JP 2021191784A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- compound
- acceptable salt
- excipient
- diluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024098153A JP7658014B2 (ja) | 2019-06-07 | 2024-06-18 | ピロリジン化合物 |
| JP2025052039A JP2025098178A (ja) | 2019-06-07 | 2025-03-26 | ピロリジン化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382477 | 2019-06-07 | ||
| EP19382477.8 | 2019-06-07 | ||
| JP2021505713A JP6940717B2 (ja) | 2019-06-07 | 2020-06-03 | ピロリジン化合物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505713A Division JP6940717B2 (ja) | 2019-06-07 | 2020-06-03 | ピロリジン化合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024098153A Division JP7658014B2 (ja) | 2019-06-07 | 2024-06-18 | ピロリジン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021191784A JP2021191784A (ja) | 2021-12-16 |
| JP2021191784A5 true JP2021191784A5 (enExample) | 2023-05-25 |
| JP7508422B2 JP7508422B2 (ja) | 2024-07-01 |
Family
ID=66821161
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505713A Active JP6940717B2 (ja) | 2019-06-07 | 2020-06-03 | ピロリジン化合物 |
| JP2021143227A Active JP7508422B2 (ja) | 2019-06-07 | 2021-09-02 | ピロリジン化合物 |
| JP2024098153A Active JP7658014B2 (ja) | 2019-06-07 | 2024-06-18 | ピロリジン化合物 |
| JP2025052039A Pending JP2025098178A (ja) | 2019-06-07 | 2025-03-26 | ピロリジン化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505713A Active JP6940717B2 (ja) | 2019-06-07 | 2020-06-03 | ピロリジン化合物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024098153A Active JP7658014B2 (ja) | 2019-06-07 | 2024-06-18 | ピロリジン化合物 |
| JP2025052039A Pending JP2025098178A (ja) | 2019-06-07 | 2025-03-26 | ピロリジン化合物 |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US11286249B2 (enExample) |
| EP (1) | EP3980409A1 (enExample) |
| JP (4) | JP6940717B2 (enExample) |
| KR (3) | KR102720992B1 (enExample) |
| CN (1) | CN114008021B (enExample) |
| AU (1) | AU2020287599B2 (enExample) |
| BR (1) | BR112021023347A2 (enExample) |
| CL (1) | CL2021003202A1 (enExample) |
| CO (1) | CO2021016295A2 (enExample) |
| CR (1) | CR20210602A (enExample) |
| DO (1) | DOP2021000254A (enExample) |
| EA (1) | EA202193007A1 (enExample) |
| EC (1) | ECSP21088515A (enExample) |
| IL (2) | IL288174B2 (enExample) |
| JO (1) | JOP20210319B1 (enExample) |
| MA (1) | MA56115A (enExample) |
| MX (2) | MX2021014913A (enExample) |
| MY (1) | MY200810A (enExample) |
| PE (1) | PE20220134A1 (enExample) |
| PH (1) | PH12021553062A1 (enExample) |
| SA (1) | SA521431048B1 (enExample) |
| SG (1) | SG11202113244UA (enExample) |
| UA (1) | UA128540C2 (enExample) |
| WO (1) | WO2020247429A1 (enExample) |
| ZA (1) | ZA202109251B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3235992A1 (en) | 2021-11-03 | 2023-05-11 | Liang Tan | Substituted phenylpropionic acid derivative and use thereof |
| MX2024009161A (es) | 2022-01-26 | 2024-08-06 | Lilly Co Eli | Compuestos de pirrolidina. |
| WO2024199070A1 (zh) * | 2023-03-24 | 2024-10-03 | 上海京新生物医药有限公司 | 一种环状胺衍生物及其组合物与应用 |
| WO2024217537A1 (zh) * | 2023-04-21 | 2024-10-24 | 深圳信立泰药业股份有限公司 | 一种叔胺类化合物及其制备方法和医药用途 |
| TW202444710A (zh) | 2023-05-11 | 2024-11-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 一種脂蛋白化合物晶型及其製備方法 |
| EP4714939A1 (en) * | 2023-05-19 | 2026-03-25 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Sulfonamide compound, preparation method therefor, and pharmaceutical use thereof |
| CN121443287A (zh) | 2023-06-30 | 2026-01-30 | 伊莱利利公司 | Lp(a)干扰剂化合物的治疗用途及剂量 |
| WO2025024211A1 (en) | 2023-07-21 | 2025-01-30 | Eli Lilly And Company | Piperidine Compounds with Lp(a) Lowering Activity |
| AU2024298539A1 (en) | 2023-07-21 | 2026-01-22 | Eli Lilly And Company | PYRROLIDINE COMPOUNDS WITH Lp(a) LOWERING ACTIVITY |
| WO2025024216A1 (en) | 2023-07-21 | 2025-01-30 | Eli Lilly And Company | PYRROLIDINE COMPOUNDS Lp(a) LOWERING ACTIVITY |
| WO2025024210A1 (en) | 2023-07-21 | 2025-01-30 | Eli Lilly And Company | Piperidine, morpholine and tetrahydro-pyridazine compounds with lp(a) lowering activity |
| CN119490445A (zh) * | 2023-08-15 | 2025-02-21 | 深圳信立泰药业股份有限公司 | 一种酰基类化合物及其制备方法和医药用途 |
| WO2025103442A1 (zh) * | 2023-11-17 | 2025-05-22 | 上海翊石医药科技有限公司 | 一种取代的2-(吡咯烷-3-基)乙酸的衍生物及其制备方法和用途 |
| WO2025108255A1 (zh) * | 2023-11-20 | 2025-05-30 | 上海齐鲁制药研究中心有限公司 | 一种多环类衍生物、其制备方法和应用 |
| WO2025237188A1 (zh) * | 2024-05-14 | 2025-11-20 | 石家庄以岭药业股份有限公司 | 一种LP(a)抑制剂化合物及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2685325B1 (fr) * | 1991-12-20 | 1994-02-04 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US7371777B2 (en) * | 2001-08-17 | 2008-05-13 | Eisai Co., Ltd. | Cyclic compound and PPAR agonist |
| AU2003300438A1 (en) | 2003-12-24 | 2005-08-03 | Esperion Therapeutics, Inc. | Ether compounds and compositions for cholesterol management and related uses |
| JP2007525408A (ja) * | 2003-12-24 | 2007-09-06 | エスペリオン セラピューティクス，インコーポレイテッド | コレステロール管理および関連使用のためのケトン化合物および組成物 |
| WO2009016048A1 (en) * | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| JP2019505508A (ja) * | 2016-02-03 | 2019-02-28 | シャンハイ ハイヤン ファーマシューティカル テクノロジー カンパニー リミテッドＳｈａｎｇｈａｉ Ｈａｉｙａｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ． | 複素環置換ｎ−スルホニルベンズアミド誘導体、その製造方法および医薬における使用 |
| CN112321475B (zh) | 2020-11-13 | 2022-06-10 | 四川大学 | 一种γ-氨基酸类似物及其合成方法 |
-
2020
- 2020-06-03 US US17/056,144 patent/US11286249B2/en active Active
- 2020-06-03 IL IL288174A patent/IL288174B2/en unknown
- 2020-06-03 WO PCT/US2020/035825 patent/WO2020247429A1/en not_active Ceased
- 2020-06-03 EP EP20747210.1A patent/EP3980409A1/en active Pending
- 2020-06-03 MA MA056115A patent/MA56115A/fr unknown
- 2020-06-03 UA UAA202106553A patent/UA128540C2/uk unknown
- 2020-06-03 AU AU2020287599A patent/AU2020287599B2/en active Active
- 2020-06-03 IL IL321703A patent/IL321703A/en unknown
- 2020-06-03 MX MX2021014913A patent/MX2021014913A/es unknown
- 2020-06-03 PE PE2021002037A patent/PE20220134A1/es unknown
- 2020-06-03 CR CR20210602A patent/CR20210602A/es unknown
- 2020-06-03 SG SG11202113244UA patent/SG11202113244UA/en unknown
- 2020-06-03 KR KR1020247002433A patent/KR102720992B1/ko active Active
- 2020-06-03 KR KR1020227043106A patent/KR102629923B1/ko active Active
- 2020-06-03 CN CN202080041924.XA patent/CN114008021B/zh active Active
- 2020-06-03 KR KR1020217040065A patent/KR102477481B1/ko active Active
- 2020-06-03 MY MYPI2021007256A patent/MY200810A/en unknown
- 2020-06-03 JP JP2021505713A patent/JP6940717B2/ja active Active
- 2020-06-03 BR BR112021023347A patent/BR112021023347A2/pt unknown
- 2020-06-03 PH PH1/2021/553062A patent/PH12021553062A1/en unknown
- 2020-06-03 EA EA202193007A patent/EA202193007A1/ru unknown
-
2021
- 2021-09-02 JP JP2021143227A patent/JP7508422B2/ja active Active
- 2021-11-18 ZA ZA2021/09251A patent/ZA202109251B/en unknown
- 2021-11-30 CO CONC2021/0016295A patent/CO2021016295A2/es unknown
- 2021-12-01 JO JOJO/P/2021/0319A patent/JOP20210319B1/ar active
- 2021-12-01 CL CL2021003202A patent/CL2021003202A1/es unknown
- 2021-12-03 MX MX2025001789A patent/MX2025001789A/es unknown
- 2021-12-07 DO DO2021000254A patent/DOP2021000254A/es unknown
- 2021-12-07 EC ECSENADI202188515A patent/ECSP21088515A/es unknown
- 2021-12-07 SA SA521431048A patent/SA521431048B1/ar unknown
-
2022
- 2022-02-15 US US17/671,806 patent/US12441714B2/en active Active
-
2024
- 2024-06-18 JP JP2024098153A patent/JP7658014B2/ja active Active
-
2025
- 2025-03-26 JP JP2025052039A patent/JP2025098178A/ja active Pending
- 2025-07-11 US US19/267,125 patent/US20260055086A1/en active Pending